Is Zuspan Regimen Adequate for Preventing Eclampsia?: A Case Report

Raymond Surya, Budi Iman Santoso, Surahman Hakim

Abstract


Magnesium sulphate (MgSO4) is believed to treat preeclampsia and eclampsia for more than a century with a total dose of MgSO4 varying from 2 to 5g per 24 hours. Zuspan and Pritchard are two internationally recommended regimens that are accepted as the standard regimen.

In this case report, we presented a 41 year old woman with puerperal preeclampsia prescribed with a complete Zuspan regimen. She had eclamptic seizure after completing Zuspan regimen with Mg SO4 level of 4.3 mg/dL.

In this case, the possibility of eclamptic seizures might be due to a lack of MgSO4 dose. The administration of MgSO4 for preeclampsia with severe features and prophylactic of eclampsia should be adjusted.

 


Keywords


Mg SO4, eclampsia, Zuspan, Pritchard

Full Text:

PDF

References


Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2014;36(5):416–41.

National Institute for Health and Care Excellence (NICE). Hypertension in Pregnancy. Clinical guideline [CG107]. London: NICE; 2010.

Hypertension in Pregnancy: Executive Summary. Obstet Gynecol. 2013;122(5):1122.

Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–7.

WHO. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia [Internet]. WHO. [cited 2018 Aug 27]. Available from: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548335/en/

Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;(11):CD000025.

Pratt JJ, Niedle PS, Vogel JP, Oladapo OT, Bohren M, Tunçalp Ö, et al. Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies. Acta Obstet Gynecol Scand. 2016;95(2):144–56.

Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG Int J Obstet Gynaecol. 2007;114(3):300–9.

Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol. 1984;150(6):728–33.

Euser AG, Cipolla MJ. Magnesium sulfate treatment for the prevention of eclampsia: A brief review. Stroke J Cereb Circ. 2009;40(4):1169–75.

Salinger DH, Mundle S, Regi A, Bracken H, Winikoff B, Vicini P, et al. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study. BJOG Int J Obstet Gynaecol. 2013;120(7):894–900.

Okusanya BO, Oladapo OT, Long Q, Lumbiganon P, Carroli G, Qureshi Z, et al. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG Int J Obstet Gynaecol. 2016;123(3):356–66.

The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. The Lancet. 1995;345(8963):1455–63.

Gordon R, Magee LA, Payne B, Firoz T, Sawchuck D, Tu D, et al. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens. J Obstet Gynaecol Can. 2014;36(2):154–63.

Dayicioglu V, Sahinoglu Z, Kol E, Kucukbas M. The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? Hypertens Pregnancy. 2003;22(3):257–65.

Anderson JK, Boyd CI. Effect of Maternal Body Mass Index on Serum Magnesium Levels Given for Seizure Prophylaxis. Obstet Gynecol. 2013;122(2 PART 1):394.




DOI: https://doi.org/10.15850/amj.v5n4.1357



 This Journal indexed by:

     

 

Creative Commons License
AMJ is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 


View My Stats